GITNUX MARKETDATA REPORT 2024

Cymbalta Efficacy Period Statistics

Cymbalta has been shown to significantly reduce symptoms of depression and anxiety over a treatment period of several weeks to several months.

Statistic 1

"Cymbalta demonstrates a remission rate of 28-33% in patients with major depressive disorder for the period of 8 weeks."

Sources Icon

Statistic 2

"By 12 weeks, 42% to 55% of patients on duloxetine 60 mg/day reportedly experienced at least a 50% reduction of pain."

Sources Icon

Statistic 3

"About 1 in 4 patients achieve remission (Hamilton Depression Rating Scale score ≤7) after 8 weeks of treatment."

Sources Icon

Statistic 4

"The efficacy of Cymbalta was established in 4 short-term and 4 long-term (6-month) placebo-controlled trials."

Sources Icon

Statistic 5

"One trial of Cymbalta for fibromyalgia showed that patients on Cymbalta had a statistically (P<0.001) and clinically meaningful reduction in pain at 3 months compared to placebo (5.2 vs 2.8, with higher scores indicating more severe pain)."

Sources Icon

Statistic 6

"Cymbalta also has a statistically significant efficacy over placebo in reducing the frequency of relapse of depressive symptoms over 38 weeks."

Sources Icon

Statistic 7

"The efficacy of Cymbalta in relieving neuropathic pain caused by fibromyalgia is similar to that demonstrated in studies of diabetic peripheral neuropathy and postherpetic neuralgia."

Sources Icon

Statistic 8

"The efficacy of Cymbalta was superior to placebo as measured by improvement in the 17-item Hamilton Depression Rating Scale total score (Study HRSD-17)."

Sources Icon

Statistic 9

"Following 7 weeks of acute treatment with CYMBALTA, 40% of patients achieved a therapeutic response."

Sources Icon

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!